| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 3.429 | 10.587 | 0 | 1.412 | 4.233 | 0 | - | - |
| Total Income - EUR | 0 | 4.899 | 4.174 | 36.960 | 3.949 | 6.597 | 13.310 | 0 | - | - |
| Total Expenses - EUR | 85 | 3.994 | 4.441 | 4.138 | 4.157 | 5.208 | 4.083 | 750 | - | - |
| Gross Profit/Loss - EUR | -85 | 905 | -267 | 32.822 | -209 | 1.389 | 9.226 | -750 | - | - |
| Net Profit/Loss - EUR | -85 | 758 | -370 | 32.504 | -209 | 1.346 | 9.099 | -750 | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Biosar Apis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.247 | 247 | 243 | 12.881 | 8.717 | 4.711 | 850 | 225 | - | - |
| Current Assets | 47 | 855 | -218 | 32.690 | 32.048 | 32.787 | 41.167 | 41.223 | - | - |
| Inventories | 0 | 0 | 0 | 54 | 53 | 52 | 4.174 | 4.187 | - | - |
| Receivables | 0 | 390 | -303 | 32.416 | 31.789 | 31.186 | 34.537 | 34.645 | - | - |
| Cash | 47 | 466 | 85 | 219 | 206 | 1.548 | 2.456 | 2.392 | - | - |
| Shareholders Funds | 45 | 802 | -326 | 32.184 | 31.352 | 32.104 | 40.491 | 39.867 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 4.250 | 301 | 351 | 745 | 930 | 912 | 901 | 953 | - | - |
| Income in Advance | 0 | 0 | 0 | 12.643 | 8.483 | 4.481 | 626 | 628 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "149 - 149" | |||||||||
| CAEN Financial Year |
149
|
|||||||||
Comments - Biosar Apis Srl